AzTrials
AzTrials

Disability EvaluationMMOMANCT02727010

Motherhood With MOtor Impairment Due to MAlady (Rare Disease)

An observational study of Disability Evaluation and Child of Impaired Parents, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background Women with rare diseases resulting in motor disabilities wishing to become mother face a major challenge. The investigators hypothesize that provided with adequate support, they are able to achieve a successful pregnancy and to offer their child a safe family environment. Read more about this study

Who is it for?
Ages 18 years and older, women only
How many people
29 participants
Where
1 siteFrance
Study dates
2 Mar 2016to 28 Nov 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Pregnant women or mothers to children < 14 months, with motor impairment, visiting the inclusion center and willing to participate in the study. Any motor impairment available, regardless of its cause.

Who may be able to join

  • Women aged 18 or older
  • Either pregnant > 14 weeks, or mother of a child < 1 year
  • With disability resulting from motor impairment
  • Giving informed consent
  • With social insurance

Who cannot join

  • Know mental retardation
  • Known psychiatric disorder
  • Not fluent in French

Trial locations and contacts

1 site in 1 country.

France1 site
  • SAPPH

    Paris, 75014

Other trials in France

About this study

Official title: Parenthood and Motherhood in Women With Motor Impairment and Disability Related to a Rare Disease

Background Women with rare diseases resulting in motor disabilities wishing to become mother face a major challenge. The investigators hypothesize that provided with adequate support, they are able to achieve a successful pregnancy and to offer their child a safe family environment.

Methods To test this hypothesis, the investigators shall conduct a prospective observational prospective survey of a consecutive series of volunteer pregnant women or mothers of children less than 14 months, with motor impairment, participating in a program of parenting support developed in our institution.

Read more

Primary outcome: social environment, child development, mother-infant attachment, mother- infant interactions Secondary outcome: social and demographic characteristics, severity of motor impairment, associated impairment, perinatal morbidity for the mother and the infant (composite indicator), emotional status, and the needs expressed by women regarding the level of medical or social care.

Analysis The investigators shall describe the distribution of the primary outcome measurements in the subgroup of women with motor impairment related to a rare disease. The investigators shall compare this distribution to the expected distribution in the general population, and to that observed in women with motor impairment unrelated to a rare disease. The investigators shall also study primary outcome measurements as a function of the severity of maternal disability, of the mother's social characteristics and emotional status.

The investigators shall also describe the distribution the distribution of perinatal morbidity globally, and as a function of the potential explanatory variables mentioned above.

The investigators shall also report on the opinion of women regarding the support they were offered so far, and the support they declare they should benefit from.

Read the detailed description

Background Women with motor disabilities have the same well-founded desire to become a mother as other women. Despite dedicated aids and adapted supportive measures, they face social blame from persons who believe they are not apt to provide adequate care to their children. When a rare disease caused the disability, planning to become a mother is even more critical, since most perinatal care providers are unfamiliar with the condition, and specialists of the disease are unfamiliar with pregnancy. Unsurprisingly, data on motherhood in women with rare diseases resulting in motor impairment are scarce.

The institutions of the investigators run a joint care program dedicated to future parents and parents with disabilities, namely:

  • Hôpital Universitaire Pitié Salpêtrière- Charles Foix (assistance Publique Hôpitaux de Paris and Université Paris 6), providing a gynecological and perinatal unit with care programs adapted to women with disabilities, plus a number of reference centers for rare neurologic and muscular diseases including research and clinical care.
  • Service d'Aide à la Parentalité des Personnes en Situation de Handicap (SAPPH, Fondation Hospitalière Sainte Marie) providing training and support to parenthood to persons with motor or sensory disabilities. This training program aims at recognizing parental capacities, and if necessary enhancing them by information, training, adapting the environment, or seeking extra human help.

The investigators felt the need to evaluate the outcome of our program, in terms of quality of infant environment, development, attachment, and interactions with their disabled mother. The investigators focused on parenthood in women with a rare disease resulting in motor impairment, a research field remaining largely unexplored so far.

Hypothesis Our hypothesis is that when provided with a specific care program, mothers with motor impairment due to a rare disease and their partners have the capacity to offer their children appropriate social environment and care, resulting in child development, mother-infant attachment, and mother- infant interactions being similar to what one would expect in women without motor impairment.

Objective Primary objective To describe social environment, child development, mother-infant attachment, mother- infant interactions, when the mother has motor impairment due du a rare disease.

Secondary objective

  1. To describe maternal and perinatal outcome when the mother has motor impairment due du a rare disease
  2. To explore a potential relation between the outcome criteria of the primary goal with
  • The severity of motor impairment
  • The causal disease
  • The personal history of the mother including her access to adapted care prior to pregnancy during pregnancy and post-partum
  • The social status of the family
  • The emotional status of the mother
  1. To compare the distribution of primary goal outcome criteria in our study population to what is expected in the general population, when appropriate
  2. To compare the distribution of primary goal outcome criteria in our study population to what we observed in women with motor impairment that does not result from a rare disease
  3. To describe the needs expressed by women regarding medical care, psychological, social, and environmental support

Eligibility criteria Please see specific box

Outcome measurements (assessed at least once before the age of 14 months, see specific box) Primary outcome Child development /Infant attachment /Social environment /Mother infant interaction/ Child protection legal decisions if applicable Secondary outcome Demographic and social characteristics Disease or event causing impairment Obstetrical history Somatic and psychic events before, during pregnancy, and post-partum History of access to care Severity of impairment and handicap Maternal emotional status Needs expressed by women regarding medical care, psychological, social, and environmental support

Study design Pre inclusion: written and verbal information on the study to all women with motor impairment seeking care either at the Pitié Salpétrière Maternity unit or at the Service d'Aide à la Parentalité pour les Personnes en Situation de Handicap (SAPPH) Inclusion visit: During a planned training session, either pre natal or post natal Follow up visit: once of twice before the child is 14 months. A specific consent of both parents will be required for all outcome criteria concerning the infant.

Research visits will take place during usual visits of our parenthood support and training program.

Analysis The investigators shall describe the distribution of the primary outcome measurements in the subgroup of women with motor impairment related to a rare disease. The investigators shall compare this distribution to the expected distribution in the general population, and to that observed in women with motor impairment unrelated to a rare disease. The investigators shall also study primary outcome measurements as a function of the severity of maternal disability, of the mother's social characteristics and emotional status.

The investigators shall also describe the distribution the distribution of perinatal morbidity globally, and as a function of the potential explanatory variables mentioned above.

the investigators shall also report on the opinion of women regarding the support they were offered so far, and the support they declare they should benefit from.

Keywords
Motor disability, Motor impairment, Pregnancy, Parenthood, Child psychology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02727010
Study groupRoleWhat they receive
mothers with motor impairment due to a rare disease20 Women with motor impairment due to a rare disease
mothers with motor impairment not related to a rare diseasecontrols, 20 women with motor impairment not related to a rare disease

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Child development Mother infant attachment - Coding Interactive Behavior - Pirgas scale - Child protection legal decisions if applicable

    Child development assessed by Brunet Lézine score: based on standardized examination of the infant by a trained child psychologist

    Measured: At least once before the age of 14 months. May be repeated twice.

  2. Infant attachment

    Infant attachment assessed by Guedenet and Fermanian ADBB scale: scale assessed by investigator

    Measured: At least once before the age of 14 months. May be repeated twice.

  3. Social environment

    Social environment assessed by Cutrona scale: self-administered questionnaire

    Measured: At least once before the age of 14 months. May be repeated twice.

  4. Mother infant interaction

    assessed by:

    • Coding Interactive Behavior: mother infant interaction filmed in a standardized fashion, and analyzed by trained psychologists blinded to the dyad's history.
    • Pirgas scale: clinical diagnosis regarding mother to infant interactions Child protection legal decisions : type of decision if applicable.

    Measured: At least once before the age of 14 months. May be repeated twice.

Secondary outcomes (10)
  1. Demographic and social characteristics

    Demographic and social characteristics, qualitative variables (Questionnaire administered by investigator)

    Measured: At lest once before the age of 14 months. May be repeated twice.

  2. Epices score of social deprivation

    Epices score of social deprivation (Self-administered questionnaire)

    Measured: At lest once before the age of 14 months. May be repeated twice.

  3. Disease or event causing impairment

    Disease or event causing impairment: preset qualitative variables (Questionnaire administered by investigator)

    Measured: At lest once before the age of 14 months. May be repeated twice.

  4. Obstetrical history

    Obstetrical history: preset qualitative variables (Questionnaire administered by investigator)

    Measured: At lest once before the age of 14 months. May be repeated twice.

  5. Somatic and psychic events before, during pregnancy, and post-partum (composite scores)

    Measured: At lest once before the age of 14 months. May be repeated twice.

  6. History of access to care

    History of access to care: standardized interview (Questionnaire administered by investigator)

    Measured: At lest once before the age of 14 months. May be repeated twice.

  7. Barthel score of capacity in everyday life

    Barthel score of capacity in everyday life (Self-administered questionnaire)

    Measured: At lest once before the age of 14 months. May be repeated twice.

  8. Ad hoc ordinal score based on the number of body parts with motor impairment and additional non-motor impairment

    Measured: At lest once before the age of 14 months. May be repeated twice.

  9. Maternal emotional status

    Assessed by STAI / EPDS scales (Self-administered questionnaire)

    Measured: At lest once before the age of 14 months. May be repeated twice.

  10. List of the needs expressed by women regarding medical care, psychological, social, and environmental support

    Assessed self-administered questionnaire

    Measured: At lest once before the age of 14 months. May be repeated twice.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Apr 2016 (estimated)
  2. Study start2 Mar 2016
  3. Primary completion28 Aug 2017
  4. Study completion28 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
29 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02727010
Sponsor's protocol ID
NI16003
Acronym
MMOMA
Status last verified
Dec 2016
First submitted
29 Mar 2016
Last updated
29 May 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Disability Evaluation and Child of Impaired Parents, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Child development Mother infant attachment - Coding Interactive Behavior - Pirgas scale - Child protection legal decisions if applicable (time frame: At least once before the age of 14 months. May be repeated twice.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2018; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in